RxPress. May/Jun Vol 16 No 3. The White House Releases Plan to Combat Antibiotic-Resistant Bacteria
|
|
- Hilda Jacobs
- 5 years ago
- Views:
Transcription
1 May/Jun 2015 Vol 16 No 3 RxPress TABLE OF CONTENTS The White House Releases Plan to Combat Antibiotic-Resistant Bacteria 1-2 FDA Requests New Data on Health Care Antiseptics 2-4 Penicillin Allergies and Skin Testing: Implications for Antimicrobial Stewarship 3-5 The White House Releases Plan to Combat Antibiotic-Resistant Bacteria In 2013, the Centers for Disease Control and Prevention (CDC) released its first report on antibiotic resistance threats in the United States. The report estimated that there are at least 2 million infections and 23,000 deaths annually that are attributed to antibiotic resistance. The report also classified the threat level of current resistant bacteria into 3 categories: urgent, serious, and concerning. Clostridium difficile, carbapenem-resistant Enterobacteriaceae (CRE), and drug-resistant Neisseria gonorrhoeae were classified as urgent threats that require immediate and aggressive action. Unlike CRE and N. gonorrhoeae infections, which are concerning due to antibiotic resistance, C. difficile infections are included in this category based on their association with overuse of antibiotics, increasing incidence, and risk of morbidity and mortality. The overall goal of this report was to raise awareness and to encourage national efforts to help prevent the further spread of resistance and to preserve future treatment options for bacterial infections. In response to the CDC report, President Barack Obama signed Executive Order in September 2014 which established efforts to address the increasing emergence of antibiotic-resistant bacteria. The Executive Order established the Task Force for Combating Antibiotic- Resistant Bacteria (CARB), whose objective was to create a National Action Plan to implement the National Strategy for CARB that was released concurrently with the Executive Order. The National Strategy for CARB addresses prevention, detection, and managing outbreaks of resistant bacteria and introduces goals and objectives to have effective antibiotics for these infections in the future. The Strategy focuses on reducing the number of resistant bacterial infections caused by organisms on the CDC s Urgent and Serious Threats list. The National Action Plan, released in March 2015, provides the framework to achieve the 5 main goals laid out by the National Strategy. Goals and selected objectives to achieve goals that are most relevant to healthcare providers are provided in Table 1. Additional objectives of the National Action Plan focus on antibiotics used in the agricultural industry. The overarching goal for animal agriculture is to eliminate antibiotics as a method for growth promotion, but still allow their use in the treatment and control of disease. One key objective of the National Action Plan is implementation of antibiotic stewardship activities in all inpatient, outpatient, and long-term care settings by Additionally for hospitals, antibiotic stewardship programs will have to comply with the CDC s Core Elements of Hospital antibiotic stewardship programs as a condition of participation for Medicare and Medicaid programs by The CDC Core Elements guidance provides a framework that allows an antibiotic stewardship program to ensure it is operating effectively to optimize antibiotic prescribing and reduce antibiotic overuse. The guidance has several elements including presence of support from hospital leadership; an established physician leader for antibiotic stewardship; support of a multidisciplinary team including pharmacy co-leaders, existence of active interventions to optimize antibiotic prescribing, tracking of prescribing and resistance, and active education. A checklist is available on the CDC website that existing antibiotic stewardship programs can use to ensure that their program is meeting these standards (available at: healthcare/implementation/checklist.html). Overall, the National Action Plan provides actionable objectives and metrics for the US government to help address the national crisis of increasing antibiotic resistance. The hope is that this action by the White House will help increase concerted efforts in improving antibiotic prescribing habits, increasing the ability to detect and track resistant infections, and incentivizing key stakeholders to develop new antibiotics and alternative therapeutics, such as vaccines. 1
2 Table 1. Goals and Selected Objectives in the National Action Plan for Combating Antibiotic-Resistant Bacteria. Goals Slow emergence of resistant bacteria and prevent the spread of resistant infections Strengthen national onehealth surveillance efforts to combat resistance Advance development and use of rapid and innovative diagnostic tests for identification and characterization of resistant bacteria Accelerate basic and applied research and development of new antibiotics, other therapeutics, and vaccines Improve international collaboration and capacities for antibiotic-resistance prevention, surveillance, control, and antibiotic research and development Selected Objectives Relevant to Healthcare Providers Strengthen antimicrobial stewardship: Hospitals will have to establish or enhance ASP by implementing CDC recommendations. a Establish state AR prevention programs: Creation of local networks with healthcare facilities and the state health department to help slow the regional spread of resistant organisms. Increase reporting of incidence of resistant infections and specific use of antibiotics to the National Health Safety Network. Create regional public health laboratory network: Sites will help in detection of outbreaks by MDROs and track their incidence and resistance mechanisms. Create repository and maintain database of genomic sequences for MDROs: Government agencies will maintain these and provide information or samples to aid in development of new antibiotics or diagnostic tests. Establish incentives for timely reporting of AR and antibiotic use data: Reporting these data to the National Health Safety Network will become part of the CMS hospital inpatient quality reporting program. Increase funding for the development of rapid diagnostics: Targets for funding include both tests that can differentiate between bacterial and viral infections and tests that can quickly analyze susceptibility profiles. Create incentives to increase use of these diagnostics in the healthcare setting. Increase support for research: Topics of interest include antibiotic resistance, mapping the gut microbiome, novel classes of antibiotics, vaccines, or non-traditional, innovative therapeutics. Create partnerships between stakeholders to encourage development of new antibiotics: Key stakeholders include the FDA, CDC, NIH, HHS, pharmaceutical companies, biotechnology companies, and academic researchers. Develop or strengthen relationships with other countries: Goals of collaboration with global health partners include increasing proficiency in detecting the WHO priority antimicrobial resistant pathogens c, increasing surveillance of AR in both humans and animals, developing a system to communicate significant threats quickly, and disseminating information to countries to promote interventions to fight AR. Support development of national action plans in other countries and provide assistance to developing nations so they can participate in AR surveillance. a Centers for Disease Control and Prevention s Core Elements of Hospital Antibiotic Stewardship Programs. b The goal of this network is to allow the CDC to monitor changes regionally and nationally in order to provide national estimates and provide benchmarking on antibiotic use to healthcare facilities. c WHO priority antimicrobial resistant pathogens: Escherichia coli (resistant to 3rd generation cephalosporins and fluoroquinolones), Klebsiella pneumoniae (resistant to 3rd generation cephalosporins and carbapenems), methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, fluroquinolone-resistant non-typhoidal Salmonella, fluoroquinolone-resistant Shigella, and Neisseria gonorrhoeae (reduced susceptibility to 3rd generation cephalosporins). Abbreviations: AR, antibiotic resistance; ASP, antibiotic stewardship program; CDC; Centers for Disease Control and Prevention; CMS, Centers for Medicare & Medicaid Services; FDA, Food and Drug Administration; HHS, Health and Human Services Department; MDRO, multi-drug resistant organism; NIH, National Institutes of Health; WHO, World Health Organization. FDA Requests New Data on Health Care Antiseptics The U.S. Food and Drug Administration (FDA) released a proposed rule for antiseptic drug products on April 30, New safety and efficacy data will be required for antiseptics used in the health care setting, including hand rubs, hand washes, surgical hand rubs, surgical hand scrubs, and preoperative skin preparations. Antiseptics used by consumers are excluded from the rule. 2
3 The proposed rule will affect health care antiseptics approved under the over-the-counter drug monograph. Active ingredients of affected antiseptics include alcohol (60% to 95%), povidone-iodine, iodine tincture, iodine topical solution, and isopropyl alcohol. A complete list of affected active ingredients can be found on the Federal Register ( Proper hand hygiene has become an essential element of prevention of nosocomial infections. The 2002 CDC hand hygiene guidelines recommend regular use of alcoholbased antiseptics for decontamination to prevent the spread of infection in the health care setting. Similarly, the 2009 World Health Organization guidelines select alcohol-based hand rub as the preferred antiseptic for hand hygiene (except when hands are visibly soiled or there is a strong suspicion for Clostridium difficile). Appropriate hand hygiene is recommended before and after direct contact with a patient, as well as before and after contact with invasive devices, bodily fluids, wound dressings, and medical equipment in the vicinity of a patient, and before and after removal of gloves. Furthermore, The Joint Commission highlights hand hygiene as a priority in their 2015 National Patient Safety Goals. Health care frequent use of antiseptics has become routine. Although the actual frequency of hand antiseptic use by health care has not been defined, studies have estimated an average of 5 to 30 applications per hour, with potentially more than 100 applications in an 8-hour shift. Health care antiseptics such as alcohol hand rubs are considered to be safe and effective for regular use. However, there are limited data on the effects of frequent and chronic use at the rates currently reported by health care. In 1994, health care antiseptic products were determined by the FDA to be generally recognized as safe and effective (GRASE). Since that time, reports have been published suggesting that antiseptics may have systemic exposure. Improvements in laboratory technology have made it possible to detect lower levels of active ingredients in the blood or tissue of health care. Considering the frequent and chronic use of antiseptics by health care, the FDA is requesting new evaluations of these products in order to reexamine their classification as GRASE. To demonstrate efficacy, antiseptics will need to have sufficient bacterial log reduction. The safety studies will need to provide data on frequent and long-term exposure to the antiseptic, reproductive toxicity, hormonal effects, and the development of antimicrobial resistance. There are several published studies that have evaluated the absorption of alcohol hand rubs using various frequencies and durations of exposure (Table 2). These studies have been limited by small numbers of participants and brief durations of exposure. While most studies found detectable levels of alcohol in the serum or breath, all levels were below the known threshold for intoxication. Limited information is available on the effects of repeated exposure to low levels of alcohol in health care over the course of their entire career; whether this may be a concern remains unknown. Additional concerns exist over the effects of any measurable levels of alcohol in pregnant or lactating health care. During the collection of additional data, the FDA recommends that health care continue to use antiseptics according to current infection control guidelines. There is no information to indicate that currently available health care antiseptics are unsafe or ineffective. The rule is expected to be finalized in October 2015, after which manufacturers will have 1 year to provide the requested data. Marketed health care antiseptics will continue to be available during this review. Penicillin Allergies and Skin Testing: Implications for Antimicrobial Stewardship One of the most common causes of hypersensitivity reactions is beta-lactam antibiotics. Penicillin, a beta-lactam antibiotic, can cause an allergic reaction that presents as urticaria, shortness of breath, and angioedema. Reactions to penicillin can be classified as immediate (within 1 hour) or delayed (days to weeks). Immediate anaphylactic reactions are mediated by immunoglobulin E (IgE), while non-ige mediated reactions may have additional causes. Penicillin is metabolized into major and minor determinants, which may illicit the immune response to form the antibodies that would cause a reaction. Since penicillin is structurally related to other beta-lactams, including cephalosporins and carbapenems, hypersensitivity reactions can also occur in patients with penicillin allergies that receive these antibiotics. Although the cross-reactivity between agents is low, many clinicians avoid beta-lactam antibiotics in the event of a documented allergy to avoid harming a patient. Previous studies have shown that not all patients with documented penicillin allergies have a true allergy. Up to 10% of patients are reported to have an allergy to penicillin, with some reactions proving to be more severe than others. Many patients report their reactions as a non-specific rash during childhood. If they received the antibiotic as an adult, adverse events such as vomiting are sometimes reported as an allergy, which may not reflect a true IgE-mediated reaction. However, 90% of patients with a documented allergy can tolerate administration of penicillin. Over time, there can be a loss of the anti-penicillin antibodies that formed from the initial penicillin exposure, rendering the patient non-allergic. When the reaction is unknown in a penicillin-allergic patient, clinicians generally choose broad spectrum antibiotics, which are reserved for multi-drug resistant organisms. In patients with an inappropriately labeled penicillin allergy, reports have shown increased medical 3
4 Table 2. Studies on Systemic Exposure of Alcohol Hand Rubs Used in Healthcare. Sample Antiseptic Exposure Extent of Systemic Absorption 10 healthy adults 52.6% isopropyl alcohol Every 10 minutes for 4 hrs 1 physician 62% ethanol 25 times over 2 hrs Not detectable in blood 5 adult healthcare 62% ethanol 50 times over 4 hrs Not detectable in blood 20 healthcare 12 adult volunteers 70% ethanol or 70% isopropanol 95% ethanol, 85% ethanol, or 55% ethanol with 10% propan-1-ol 1 volunteer 70% ethanol or 56% ethanol with 9% isopropanol 32 adults 63.14% propan-2-ol or 45% propan-2-ol with 30% propan-1-ol 12 healthcare 70% ethanol 30 times over 1 hr, applied 70% isopropanol 30 times over 1 hr 20 times over 30 minutes for hygienic hand disinfection; applied 10 times over 30 minutes for surgical hand disinfection Once over 30 seconds for hygienic hand disinfection; applied twice for 45 seconds for each surgical hand disinfection 20 times over 30 minutes for hygienic hand rub; applied 10 times over 80 minutes for surgical hand rub 70% ethanol Twice over 10 minutes, 3 times over 8 minutes, or 9 times over 50 minutes for hygienic hand rub; applied twice over 2 minutes for surgical hand rub Ethanol detectable on breath and in blood (not toxic); isopropanol not detectable Detectable vapor in air; estimated absorption not toxic Detectable in vapor in air; estimated absorption not toxic costs, risk of antibiotic resistance, length of stay, and intensive care unit (ICU) admission in addition to higher mortality. One of the most useful and reliable detection methods for a true penicillin allergy is the penicillin skin test. Skin testing can demonstrate the presence of penicillin-specific IgE in the body. In patients with a non-ige mediated reaction, skin testing is contraindicated. Examples of non-ige mediated reactions include Stevens-Johnson Syndrome, serum sickness, or drug rash with eosinophilia and systemic symptoms. To complete a skin test, a patient is exposed to a positive and negative control, and major and minor penicillin determinants. These reagents are pricked into the skin, and the reaction is measured. If there is a positive reaction to the skin test, defined as >3 mm of erythema surrounding the injection site, a patient should not receive the intradermal test. If there is no growth around the site, the reagents are intradermally injected. If the intradermal test also has no reaction, an oral challenge with penicillin or amoxicillin may follow, with 60 minutes of observation time. The test has been found to have a high specificity to exclude the allergy correctly (97% to 100%), but lower sensitivity to identify the allergy correctly (29% to 68%). There are few adverse events reported in patients with a negative skin test, however events are dependent on if the patient had a previous IgE-mediated reaction. There are multiple patient care settings where penicillin skin testing can have an impact on antimicrobial stewardship and patient care, including the ICU, the emergency department (ED), and cardiac surgery. Approximately 90% of patients in various ICUs who received a penicillin skin test had a negative result. These negative results can lead to changes in the patients therapy to include a beta-lactam antibiotic if necessary. Use of beta-lactams reduces the use of antibiotics reserved for multi-drug resistant organisms, including fluoroquinolones, vancomycin, and carbapenems. In a study of patients with self-reported penicillin allergies in the ED, 137 patients out of a sample of 150 patients (91%) had a negative penicillin skin test result and not a true IgE-mediated allergy. The test only took 30 minutes to produce a result, which was efficient for an ED setting. In patients undergoing cardiac surgery, the appropriate antibiotic choice is essential to avoid potential toxicities that may result in negative cardiovascular outcomes. In a study of 276 patients with a penicillin allergy referred for testing prior to cardiac surgery, 38 had a positive skin test result. After testing, there was a 91% reduction in the 4
5 amount of vancomycin used in the operating room prior to cardiac surgery, thus reducing unnecessary vancomycin. There were no adverse events reported in patients with negative results. However, penicillin skin testing is not appropriate for all patients. If there is a recent history of an IgE-mediated reaction or severe dermatologic reaction to a beta-lactam, testing should be avoided to reduce the chance of an adverse reaction. Penicillin skin testing is a cost-effective way to determine if a patient has a true penicillin allergy, since the cost of broad spectrum antibiotics used in place of penicillin is higher. The cost of reagent and testing equipment can be up to $130, and the time to a result is approximately 30 to 60 minutes. In a 4 month prospective chart review, 146 patients with a reported penicillin allergy were given a penicillin skin test as part of an antimicrobial stewardship program. Patients were identified from the antimicrobial stewardship database. The decision to alter the therapy to a beta-lactam antibiotic was based on microbiologic data, IgE-mediated reaction, infection, and laboratory values. Patients with certain skin conditions, non-ige mediated reactions, additional or unknown allergies to antibiotics or recent anaphylaxis were excluded. Patients were initially given a skin prick test and monitored. If there was a negative result, the patient was then exposed to the intradermal reagent, and then an oral penicillin challenge based on response. Out of all the patients tested, only 1 had a positive reaction; the other 145 were negative to both the skin test and a subsequent oral challenge. Patients with a negative result were transitioned to a betalactam antibiotic. There were no reactions at 24 hours for these patients, which resulted in a negative predictive value of 100%. The cost reduction with use of a penicillin skin test was approximately $520 per patient. Additional costs associated with catheters, laboratory work, wound dressing changes, and other medications were avoided. The estimated cost of therapy if the penicillin skin test had not been performed was $113,991. The cost after the betalactam transition was $81,180, resulting in a difference of $225 saved per patient during the study period. In patients with a negative skin test, there is a potential for up to an $82,000 savings per year by switching to a betalactam. The authors concluded that the use of skin testing can improve antimicrobial stewardship and save costs associated with antibiotic use. Integrating penicillin skin testing into an antimicrobial stewardship program is one way to ensure that patients with documented penicillin allergies are tested. By incorporating penicillin skin testing into an antimicrobial stewardship program and making it a standard of care, there are many opportunities to prevent unnecessary adverse events, reduce costs, and ensure antibiotics used for multi-drug resistant infections are preserved. Incorporating histories and risk stratification provide important information so that patients can be properly tested. One proposed model can be remembered by the 3 A s: alert, assessment, and action. By identifying patients with antibiotic allergies and alerting clinicians that are part of the antimicrobial stewardship team, those patients can be assessed. After the in vitro and in vivo data from the patient have been assessed, the patient s allergy status can be determined: IgE-mediated or non-allergic. Lastly, the action can take place: the patient can be tested or desensitized. Based on the results from the test, appropriate therapy can be administered to the patient. Pharmacists can play an important role in antimicrobial stewardship by interacting with patients and other healthcare providers. By taking detailed allergy histories and discussing the reaction with patients they can help to identify patients that would be appropriate for testing. They can also recommend appropriate therapy after the patient has been tested. By integrating penicillin skin testing with antimicrobial stewardship, there are many opportunities for pharmacists and physicians to reduce broad spectrum antibiotic use, adverse events, and costs. More appropriate antibiotics can be prescribed and monitored, all while improving patient outcomes. Authors: Nicole Mueller PharmD, BCPS Samantha Spencer PharmD Carol Poskay PharmD Editors: Ryan Rodriguez PharmD, BCPS Lara Ellinger PharmD, BCPS 5
11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationImplementing Antibiotic Stewardship in Rural and Critical Access Hospitals
National Center for Emerging and Zoonotic Infectious Diseases Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals Denise Cardo, MD Director, Division of Healthcare Quality Promotion,
More informationInternational Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals
International Food Safety Authorities Network (INFOSAN) 7 March 2008 INFOSAN Information Note No. 2/2008 - Antimicrobial Resistance Antimicrobial Resistance from Food Animals SUMMARY NOTES Antimicrobial
More informationTelligen Outpatient Antibiotic Stewardship Initiative. The Renal Network March 1, 2017
Telligen Outpatient Antibiotic Stewardship Initiative The Renal Network March 1, 2017 Who is Telligen? What is the QIN-QIO Program? Telligen: The Medicare Quality Innovation Network (QIN)-Quality Improvement
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationAntibiotic Stewardship and Critical Access Hospitals. Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network
Antibiotic Stewardship and Critical Access Hospitals Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network Antibiotic-Resistant Bacteria A serious threat to public health and the economy
More informationGeriatric Mental Health Partnership
Geriatric Mental Health Partnership September 8, 2017 First, let s test your knowledge about antibiotics http://www.cdc.gov/getsmart/community/about/quiz.html 2 Get Smart Antibiotics Quiz Antibiotics fight
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationAntimicrobial Stewardship in the Hospital Setting
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor
More informationUSA ACTION PLAN FOR COMBATING ANTIBIOTIC-RESISTANT BACTERIA
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationCombating Antimicrobial Resistance: The Way Forward
Combating Antimicrobial Resistance: The Way Forward James M. Hughes, MD Professor of Medicine and Public Health Emory University Atlanta, GA NIAA Antibiotic Symposium November 14, 2014 Disclosure No conflicts
More informationASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies
ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension
More informationAntibiotic Stewardship Beyond Hospital Walls
Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship
More informationAntibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationNursing Home Online Training Sessions Session 2: Exploring Antibiotics and Their Role in Fighting Bacterial Infections
National Nursing Home Quality Care Collaborative Nursing Home Online Training Sessions Session 2: Exploring Antibiotics and Their Role in Fighting Bacterial Infections Health Services Advisory Group (HSAG)
More informationPreventing and Responding to Antibiotic Resistant Infections in New Hampshire
Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Benjamin P. Chan, MD, MPH NH Dept. of Health & Human Services Division of Public Health Services May 23, 2017 To bring a greater
More informationHot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital
Hot Topics in Antimicrobial Stewardship Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Antimicrobial Stewardship Goals Primary Goal Optimize clinical outcomes
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Preventing the Spread of Antibiotic Resistance and Improving Patient Care (Adapted from the Centers for Disease Control and Prevention) What is Stewardship? Antimicrobial stewardship
More informationWHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health
New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries 30 APRIL 2014 GENEVA - A new report by WHO its first to look at antimicrobial resistance,
More informationOBJECTIVES. Fast Facts 3/23/2017. Antibiotic Stewardship Beyond Hospital Walls. Antibiotics are a shared resource and becoming a scarce resource.
Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship
More informationAdvancing Antimicrobial Stewardship in Community and Rural Hospitals
Advancing Antimicrobial Stewardship in Community and Rural Hospitals Whitney Buckel, PharmD, BCPS Infectious Diseases Clinical Pharmacist Intermountain Medical Center Disclosures The SCORE study was supported
More informationAntibiotic Stewardship in the LTC Setting
Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship
More informationComments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014
Comments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014 The Pew Charitable Trusts is an independent, nonprofit organization
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationPhysician Rating: ( 23 Votes ) Rate This Article:
From Medscape Infectious Diseases Conquering Antibiotic Overuse An Expert Interview With the CDC Laura A. Stokowski, RN, MS Authors and Disclosures Posted: 11/30/2010 Physician Rating: ( 23 Votes ) Rate
More informationMulti-Drug Resistant Organisms (MDRO)
Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause
More informationUpdates in Antimicrobial Stewardship
Updates in Antimicrobial Stewardship Andrew Hunter, Pharm.D., BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center andrew.hunter@va.gov Disclosures No disclosures
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationMHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative
MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here Nov. 14, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Please use the chat box to ask questions!
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More informationAntimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016
Antimicrobial Stewardship in the Outpatient Setting ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Abbreviations AMS - Antimicrobial Stewardship Program OP - Outpatient OPS - Outpatient Setting
More informationOverview of Infection Control and Prevention
Overview of Infection Control and Prevention Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry Green and Salah Gammouh
More informationImagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening
Multi-Drug Resistant Superbugs- What s the Big Deal? Toni Biasi, RN MSN MPH CIC Infection Prevention Indiana University Health Imagine A World Without Antibiotics A World Where Simple Infections can be
More informationAntibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship
Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship J. Hudson Garrett Jr., PhD, MSN, MPH, FNP-BC, PLNC, CDONA, IP-BC, GDCN, CDP, CADDCT, CALN, VA-BC, AS-BC,
More informationImpact of Antimicrobial Stewardship Program
Impact of Antimicrobial Stewardship Program Ripal Joshi, Pharm.D. AAHIVP Tampa General Hospital January 28, 2016 Objectives Provide an overview on antimicrobial stewardship programs (ASP) Describe the
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More information3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats
Antibiotics --When Less is More Ralph Gonzales, MD, MSPH Associate Dean, Clinical Innovation School of Medicine VP, Clinical Innovation, UCSF Health Most Urgent Threats Serious Threats Multidrug-Resistant
More informationWhat is an Antibiotic Stewardship Program?
What is an Antibiotic Stewardship Program? Jane Rogers, R.N. Anne Messer, MPH Learning Session #4 August 15, 2017 National Nursing Home Quality Care Collaborative Change Package Change Bundle: To prevent
More informationAntimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD
Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an
More informationAntibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University
Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine Mike Apley Kansas State University Changes in Food Animal Antibiotic Use How the uses of antibiotics in
More informationResolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]
United Nations A/RES/71/3 General Assembly Distr.: General 19 October 2016 Seventy-first session Agenda item 127 Resolution adopted by the General Assembly on 5 October 2016 [without reference to a Main
More informationReady to Launch: Antimicrobial Stewardship for All!
Ready to Launch: Antimicrobial Stewardship for All! Lucas Schulz, PharmD, BCPS AQ ID Clinical Coordinator Infectious Diseases PGY2 Infectious Diseases Residency Program Director Disclosures Consultant
More informationCommonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities
Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we
More informationAntimicrobial Stewardship: Guidelines for its Implementation
Antimicrobial Stewardship: Guidelines for its Implementation Loliet Gonzalez Martinez, Pharm.D. Palmetto General Hospital PGY-1 Pharmacy Resident Disclosure The author of this presentation has nothing
More informationChallenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
More informationObjective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest
Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial
More informationIt s Time to Regulate Antimicrobial Stewardship Standards in Acute Care Settings. Emily Heil, PharmD, BCPS-AQ ID, AAHIVP
It s Time to Regulate Antimicrobial Stewardship Standards in Acute Care Settings Emily Heil, PharmD, BCPS-AQ ID, AAHIVP Conflict of Interest I have no conflicts of interest to disclose related to the content
More informationAntibiotic Stewardship in Human Health- Progress and Opportunities
National Center for Emerging and Zoonotic Infectious Diseases Antibiotic Stewardship in Human Health- Progress and Opportunities CAPT Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship Division
More informationNational Action Plan development support tools
National Action Plan development support tools Sample Checklist This checklist was developed to be used by multidisciplinary teams in countries to assist with the development of their national action plan
More information6/15/2017 PART 1: THE PROBLEM. Objectives. What is Antimicrobial Resistance? Conflicts of Interest Disclosure Statement
Conflicts of Interest Disclosure Statement Getting a grasp on Antibiotic Use and Resistance: Principles of Antimicrobial Stewardship Speaker has nothing to disclose. Jacob M Kesner, PharmD UNMH PGY-2 Infectious
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Background Why Antimicrobial Stewardship 30-50% of antibiotic use in hospitals are unnecessary or inappropriate Appropriate antimicrobial use is a medication-safety and patient-safety
More informationSo Why All the Fuss About Hand Hygiene?
CARING PROFESSIONAL SERVICES, INC. HAND HYGIENE In-Service So Why All the Fuss About Hand Hygiene? Most common mode of transmission of pathogens is via hands! Infections acquired in healthcare Spread of
More informationAntimicrobial Stewardship: A Public Health Priority
Antimicrobial Stewardship: A Public Health Priority CLSI Workshop June 28, 2014 Kavita K. Trivedi, MD Principal, Trivedi Consults, LLC Adjunct Clinical Assistant Professor of Medicine, Stanford University
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationBest Practices for Antimicrobial Stewardship Programs. October 25, :00 AM 5:00 PM New Orleans, LA Room:
Best Practices for Antimicrobial Stewardship Programs October 25, 2016 8:00 AM 5:00 PM New Orleans, LA Room: 288-290 Co-organized by The Society for Healthcare Epidemiology of America (SHEA) and Pediatric
More informationAntibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationWENDY WILLIAMS, MT(AMT) MSAH DIRECTOR LABORATORY AND PATHOLOGY SERVICES. Appalachian Regional Healthcare System apprhs.org
Incorporating Automation and Rapid Diagnostic Technologies into the Micro Lab's Lean Workflow to Boost Productivity, Shorten Length of Stay, and Improve Antibiotic Utilization WENDY WILLIAMS, MT(AMT) MSAH
More informationThe Rise of Antibiotic Resistance: Is It Too Late?
The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the
More informationAntimicrobial stewardship
Antimicrobial stewardship Magali Dodemont, Pharm. with the support of Wallonie-Bruxelles International WHY IMPLEMENT ANTIMICROBIAL STEWARDSHIP IN HOSPITALS? Optimization of antimicrobial use To limit the
More informationMike Apley Kansas State University
Mike Apley Kansas State University 2003 - Daptomycin cyclic lipopeptides 2000 - Linezolid - oxazolidinones 1985 Imipenem - carbapenems 1978 - Norfloxacin - fluoroquinolones 1970 Cephalexin - cephalosporins
More informationAntimicrobial Resistance Update for Community Health Services
Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs
More informationCanada s Activities in Combatting Antimicrobial Resistance. Presentation to the JPIAMR Management Board March 29, 2017
Canada s Activities in Combatting Antimicrobial Resistance Presentation to the JPIAMR Management Board March 29, 2017 AMR in Canada Surveillance data indicates that rates of infection for some resistant
More informationAntimicrobial Stewardship Program 2 nd Quarter
Antimicrobial Stewardship Program 2 nd Quarter May 19, 2016 Jill Hanson, WHA DeAnn Richards, MetaStar Objectives for Today Hospital Highlight UnityPoint Health - Meriter Status of the state Update on pilot
More informationDr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional
Dr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional Medical Center Cancer Treatment Centers of America May
More informationAntimicrobial Stewardship Program. Jason G. Newland MD, MEd Miranda Nelson, PharmD
Antimicrobial Stewardship Program Jason G. Newland MD, MEd Miranda Nelson, PharmD The Children's Mercy Hospital, 2015 Antibiotic Timeline Clatworthy 2007 Antibiotic Use in Freestanding Children s Hospitals
More informationREPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT
1 REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT The Department of Health organised a summit on Antimicrobial Resistance (AMR) the purpose of which was to bring together all stakeholders involved
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationUsing Data to Track Antibiotic Use and Outcomes
Using Data to Track Antibiotic Use and Outcomes Michelle Nemec, PharmD Thrifty White Drug Pharmacy Objectives Describe the Antibiotic Stewardship Core Element of tracking and the specific interventions
More informationCMS Antibiotic Stewardship Initiative
CMS Antibiotic Stewardship Initiative Mary Fermazin, MD, MPA Chief Medical Officer Vice President, Health Policy and Quality Measurement Health Services Advisory Group (HSAG) March 11, 2017 Disclosure
More informationAntimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance
Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance Natalie Weber, PharmD PGY2 Critical Care Pharmacy Resident September 22, 2016 The speaker has no actual or potential conflicts of
More informationAuthor - Dr. Josie Traub-Dargatz
Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 4: Antibiotic Resistance Author M.P. Stevens, MD, MPH S. Mehtar, MD R.P. Wenzel, MD, MSc Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues
More informationAustralia s response to the threat of antimicrobial resistance
Australia s response to the threat of antimicrobial resistance Professor Warwick Anderson AM Chief Executive Officer National Health and Medical Research Council Australia s health system Antimicrobial
More informationBugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care
Bugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care Molly Curran, PharmD, BCPS Clinical Assistant Professor The University of Texas College of Pharmacy Clinical
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationEpidemiology and Economics of Antibiotic Resistance
Epidemiology and Economics of Antibiotic Resistance Eili Y. Klein February 17, 2016 Health Watch USA Meeting I. The burden of antibiotic resistance is a growing global threat, but hard numbers are lacking
More informationANTIBIOTICS IN THE ER:
ANTIBIOTICS IN THE ER: EXPLORING THE ROLE OF ANTIMICROBIAL STEWARDSHIP IN THE EMERGENCY DEPARTMENT ANGELINA DAVIS, PHARMD, MS, BCPS (AQ-ID) LIAISON CLINICAL PHARMACIST DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationAntimicrobial stewardship: Quick, don t just do something! Stand there!
Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger
More informationAntibiotic Stewardship: The Facility Role and Implementation. Tim Cozad, LPN, Lead LTC Health Facilities Surveyor
Antibiotic Stewardship: The Facility Role and Implementation Tim Cozad, LPN, Lead LTC Health Facilities Surveyor Phase II CMS Regulatory Changes Current information available includes: New Survey Process
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationMultidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical
More informationHealthcare-associated Infections and Antimicrobial Use Prevalence Survey
Healthcare-associated Infections and Antimicrobial Use Prevalence Survey Shamima Sharmin, M.B.B.S., MSc, MPH Emerging Infections Program New Mexico Department of Health Agenda Recognize healthcare-associated
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More informationCurricular Components for Infectious Diseases EPA
Curricular Components for Infectious Diseases EPA 1. EPA Title Promoting antimicrobial stewardship based on microbiological principles 2. Description of the A key role for subspecialists is to utilize
More informationAntimicrobial Stewardship in Scotland
Antimicrobial Stewardship in Scotland UKCPA/FIS Scientific Meeting 18 th November 2010 Triumphs and Unintended Consequences Dr Jacqueline Sneddon Project Lead for Scottish Antimicrobial Prescribing Group
More informationThe Role of Academic Veterinary Medicine in Combating Antimicrobial Resistance
The Role of Academic Veterinary Medicine in Combating Antimicrobial Resistance Andrew T. Maccabe, DVM, MPH, JD Chief Executive Officer NIAA Herndon, VA October 31, 2017 One Health Approach Global Health
More informationAntimicrobial Resistance, yes we care! The European Joint Action
Antimicrobial Resistance, yes we care! The European Joint Action Context of the Joint Action General objectives Inclusive governance Conclusion Context of the Joint Action 1. Context of this Joint Action
More informationThird Global Patient Safety Challenge. Tackling Antimicrobial Resistance
Geneva 12 th -13 th March 2009 Day 1, 12 th March Third Global Patient Safety Challenge Tackling Antimicrobial Resistance Edward Kelly, Coordinator, WHO Patient Safety Programme welcomed all participants
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health and food audits and analysis REFERENCES: ECDC, MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; 2017 DG(SANTE)/2017-6248 EXECUTIVE SUMMARY
More informationWhat bugs are keeping YOU up at night?
What bugs are keeping YOU up at night? Barbara DeBaun, RN, MSN, CIC 26 th Annual Medical Surgical Nursing Conference South San Francisco, CA April 15, 2016 Objectives Describe the top three infectious
More informationAntibiotic resistance is one of the biggest threats to global health, food security, and development today.
Antibiotic resistance Fact sheet Updated November 2017 Key facts Antibiotic resistance is one of the biggest threats to global health, food security, and development today. Antibiotic resistance can affect
More informationHorizontal vs Vertical Infection Control Strategies
GUIDE TO INFECTION CONTROL IN THE HOSPITAL Chapter 14 Horizontal vs Vertical Infection Control Strategies Author Salma Abbas, MBBS Michael Stevens, MD, MPH Chapter Editor Shaheen Mehtar, MBBS. FRC Path,
More informationA Conversation with Dr. Steve Solomon and Dr. Jean Patel on Antimicrobial Resistance June 18 th, 2013
A Conversation with Dr. Steve Solomon and Dr. Jean Patel on Antimicrobial Resistance June 18 th, 2013 Participant List Dr. Steve Solomon, Director, Office of Antimicrobial Resistance, Division of Healthcare
More informationDevelopment and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics
Priority Topic B Diagnostics Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics The overarching goal of this priority topic is to stimulate the design,
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More information